Pablo Oppezzo

Cp 11400
Montevideo, MO 11400, Uruguay

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL.

Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL.

Journal: Blood advances

Published: January 31, 2025

PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease.

PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease.

Journal: Science advances

Published: September 21, 2022

TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression.

TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression.

Journal: Cancers

Published: February 17, 2022

Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production.

Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 28, 2022

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Journal: Annals of hematology

Published: March 05, 2021

AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Journal: Frontiers in oncology

Published: November 27, 2020

Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.

Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.

Journal: International journal of biological macromolecules

Published: October 19, 2020

AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.

AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.

Journal: Blood

Published: August 13, 2020

Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.

Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.

Journal: Cancer immunology, immunotherapy : CII

Published: July 16, 2019

Overview of High-Throughput Cloning Methods for the Post-genomic Era.

Overview of High-Throughput Cloning Methods for the Post-genomic Era.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 04, 2019

Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.

Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.

Journal: Hematological oncology

Published: June 05, 2019

Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.

Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.

Journal: Blood

Published: September 24, 2018

Showing 1-12 of 35

Last Updated: 09/26/2026